Cismadinone acetate

Cismadinone acetate is a synthetic steroidal progestin of the 17α-hydroxyprogesterone group. It is used in veterinary medicine and has been studied for its potential applications in human medicine.
Chemical Structure and Properties[edit]
Cismadinone acetate is a derivative of hydroxyprogesterone, specifically the 17α-acetate ester of 6-chloro-17α-hydroxyprogesterone. Its chemical formula is C23H29ClO4, and it has a molecular weight of 404.93 g/mol.
Pharmacology[edit]
As a progestin, cismadinone acetate mimics the effects of the natural hormone progesterone. It binds to progesterone receptors in the body, leading to changes in the endometrium and inhibition of ovulation. This makes it useful in various hormonal therapies.
Medical Uses[edit]
Cismadinone acetate has been primarily used in veterinary medicine for the control of estrus in animals. It has also been investigated for potential use in contraception and hormone replacement therapy in humans, although it is not widely used for these purposes.
Side Effects[edit]
The side effects of cismadinone acetate are similar to those of other progestins and may include weight gain, fluid retention, and changes in menstrual cycles. Long-term use may increase the risk of certain cancers and cardiovascular disease.
Synthesis[edit]
The synthesis of cismadinone acetate involves the chemical modification of progesterone to introduce a chlorine atom at the 6-position and an acetate group at the 17α-position. This process typically involves multiple steps, including halogenation and esterification.
Regulation and Availability[edit]
Cismadinone acetate is regulated as a prescription medication in many countries. Its availability may vary depending on local regulations and approved uses.
See Also[edit]
References[edit]
External Links[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian